Annual ROE
-159.21%
+139.76%+46.75%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual return on equity is -159.21%, with the most recent change of +139.76% (+46.75%) on December 31, 2023.
- During the last 3 years, AXSM annual ROE has fallen by -68.78% (-76.06%).
- AXSM annual ROE is now -184.97% below its all-time high of 187.37%, reached on December 31, 2014.
Performance
AXSM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-194.28%
-37.84%-24.19%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly return on equity is -194.28%, with the most recent change of -37.84% (-24.19%) on September 30, 2024.
- Over the past year, AXSM quarterly ROE has dropped by -69.76% (-56.02%).
- AXSM quarterly ROE is now -140.80% below its all-time high of 476.20%, reached on September 30, 2015.
Performance
AXSM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AXSM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.8% | -56.0% |
| 3 y3 years | -76.1% | -25.4% |
| 5 y5 years | +95.2% | +54.8% |
AXSM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.9% | -78.5% | +71.4% |
| 5 y | 5-year | -316.3% | +80.9% | -207.8% | +71.4% |
| alltime | all time | -185.0% | +95.2% | -140.8% | +71.4% |
Axsome Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -194.28%(+24.2%) |
| Jun 2024 | - | -156.44%(+5.1%) |
| Mar 2024 | - | -148.91%(+19.6%) |
| Dec 2023 | -159.21%(-46.7%) | -124.52%(+14.4%) |
| Sep 2023 | - | -108.86%(-20.6%) |
| Jun 2023 | - | -137.09%(-29.4%) |
| Mar 2023 | - | -194.21%(-23.0%) |
| Dec 2022 | -298.97%(-64.2%) | -252.19%(-20.0%) |
| Sep 2022 | - | -315.19%(-53.6%) |
| Jun 2022 | - | -679.60%(+74.4%) |
| Mar 2022 | - | -389.73%(+68.9%) |
| Dec 2021 | -834.29%(+822.6%) | -230.72%(+48.9%) |
| Sep 2021 | - | -154.94%(+42.1%) |
| Jun 2021 | - | -109.06%(+36.6%) |
| Mar 2021 | - | -79.81%(+8.5%) |
| Dec 2020 | -90.43%(+136.5%) | -73.57%(+16.5%) |
| Sep 2020 | - | -63.13%(-17.4%) |
| Jun 2020 | - | -76.42%(-22.5%) |
| Mar 2020 | - | -98.57%(-18.1%) |
| Dec 2019 | -38.24% | -120.33%(-72.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -430.10%(+10.2%) |
| Jun 2019 | - | -390.26%(-30.9%) |
| Mar 2019 | - | -564.78%(-3.0%) |
| Dec 2018 | -3301.58%(+1806.9%) | -582.17%(+87.3%) |
| Sep 2018 | - | -310.88%(+53.3%) |
| Jun 2018 | - | -202.82%(+35.6%) |
| Mar 2018 | - | -149.52%(+10.5%) |
| Dec 2017 | -173.14%(+37.3%) | -135.26%(+6.0%) |
| Sep 2017 | - | -127.55%(+9.6%) |
| Jun 2017 | - | -116.33%(+13.0%) |
| Mar 2017 | - | -102.97%(+19.1%) |
| Dec 2016 | -126.10%(+379.7%) | -86.43%(+40.2%) |
| Sep 2016 | - | -61.65%(-5.5%) |
| Jun 2016 | - | -65.21%(-13.7%) |
| Mar 2016 | - | -75.55%(-11.0%) |
| Dec 2015 | -26.29%(-114.0%) | -84.92%(-117.8%) |
| Sep 2015 | - | 476.20%(+312.5%) |
| Jun 2015 | - | 115.45%(-4.8%) |
| Mar 2015 | - | 121.23%(+122.8%) |
| Dec 2014 | 187.37%(+75.4%) | 54.41% |
| Dec 2013 | 106.84% | - |
FAQ
- What is Axsome Therapeutics annual return on equity?
- What is the all time high annual ROE for Axsome Therapeutics?
- What is Axsome Therapeutics annual ROE year-on-year change?
- What is Axsome Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly ROE year-on-year change?
What is Axsome Therapeutics annual return on equity?
The current annual ROE of AXSM is -159.21%
What is the all time high annual ROE for Axsome Therapeutics?
Axsome Therapeutics all-time high annual return on equity is 187.37%
What is Axsome Therapeutics annual ROE year-on-year change?
Over the past year, AXSM annual return on equity has changed by +139.76% (+46.75%)
What is Axsome Therapeutics quarterly return on equity?
The current quarterly ROE of AXSM is -194.28%
What is the all time high quarterly ROE for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly return on equity is 476.20%
What is Axsome Therapeutics quarterly ROE year-on-year change?
Over the past year, AXSM quarterly return on equity has changed by -69.76% (-56.02%)